In the cohort with wide PP and age > or = 65 years , olmesartan 20 and 40 mg/day produced mean reductions in SBP of 21.8 and 22.5 mm Hg , and PP of 6.7 and 7.6 mm Hg , respectively ( P < .05 v placebo ) .
